Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bolni Nagalo

Concepts (211)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
31
3.980
 Why?
Hepatitis B
8
2023
23
2.140
 Why?
Oncolytic Virotherapy
3
2022
17
1.710
 Why?
HIV Infections
11
2021
357
1.600
 Why?
Hepatitis B Surface Antigens
4
2018
9
1.540
 Why?
Syphilis
7
2019
27
1.330
 Why?
Liver Neoplasms
5
2024
328
1.250
 Why?
Carcinoma, Hepatocellular
4
2023
193
1.170
 Why?
Hepatitis C
5
2021
79
1.150
 Why?
Blood Transfusion
3
2021
126
1.150
 Why?
Seroepidemiologic Studies
10
2021
43
0.920
 Why?
Burkina Faso
16
2023
16
0.900
 Why?
Vesicular Stomatitis
1
2022
1
0.840
 Why?
Enzyme-Linked Immunosorbent Assay
4
2018
244
0.760
 Why?
Biliary Tract Neoplasms
4
2022
9
0.750
 Why?
HIV Antibodies
1
2018
10
0.650
 Why?
Blood-Borne Pathogens
1
2018
7
0.650
 Why?
HIV-1
4
2018
55
0.590
 Why?
Gabon
4
2019
4
0.520
 Why?
Mass Screening
1
2018
346
0.510
 Why?
Rural Population
1
2018
537
0.460
 Why?
Young Adult
11
2021
3981
0.460
 Why?
Skin Neoplasms
3
2024
492
0.440
 Why?
Humans
36
2024
50208
0.430
 Why?
HIV Seroprevalence
2
2014
4
0.420
 Why?
Vesiculovirus
2
2022
5
0.420
 Why?
Cholangiocarcinoma
2
2022
26
0.400
 Why?
Bile Duct Neoplasms
2
2022
29
0.400
 Why?
Adolescent
10
2021
6390
0.390
 Why?
Antibodies, Viral
1
2011
88
0.380
 Why?
Plasma
1
2011
42
0.370
 Why?
Adult
16
2021
13324
0.370
 Why?
Communicable Diseases
1
2011
55
0.370
 Why?
Melanoma
2
2024
290
0.320
 Why?
Prevalence
6
2018
951
0.290
 Why?
Female
17
2021
26635
0.280
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
990
0.280
 Why?
Middle Aged
12
2020
12206
0.280
 Why?
Cell Line, Tumor
4
2024
1416
0.270
 Why?
Male
14
2021
25399
0.270
 Why?
Sensitivity and Specificity
2
2018
863
0.270
 Why?
Antineoplastic Agents
3
2024
1186
0.260
 Why?
Hepacivirus
2
2018
104
0.260
 Why?
Cell Proliferation
4
2024
1013
0.240
 Why?
Molecular Docking Simulation
2
2023
75
0.240
 Why?
Monophenol Monooxygenase
1
2023
5
0.230
 Why?
Animals
7
2024
13246
0.230
 Why?
Incidence
2
2021
1006
0.230
 Why?
Carcinoma, Pancreatic Ductal
1
2024
31
0.230
 Why?
Anti-HIV Agents
2
2014
42
0.220
 Why?
Drug Synergism
2
2021
151
0.220
 Why?
Hepatitis B virus
2
2023
27
0.210
 Why?
Psoriasis
1
2023
30
0.210
 Why?
Doxorubicin
1
2024
239
0.210
 Why?
Vesicular stomatitis Indiana virus
1
2022
4
0.210
 Why?
Dermatitis
1
2023
36
0.210
 Why?
Antioxidants
2
2023
241
0.200
 Why?
Mice
5
2024
5759
0.200
 Why?
Students, Medical
1
2023
155
0.190
 Why?
Treponema pallidum
2
2018
10
0.190
 Why?
Pancreatic Neoplasms
1
2024
208
0.190
 Why?
Flavonols
1
2020
2
0.190
 Why?
Risk Factors
4
2020
3629
0.190
 Why?
Viral Proteins
1
2022
156
0.180
 Why?
Disease Models, Animal
2
2023
1458
0.180
 Why?
Cymbopogon
1
2020
1
0.180
 Why?
Oils, Volatile
1
2020
12
0.180
 Why?
Immunotherapy
2
2021
240
0.180
 Why?
Receptors, KIR
1
2019
13
0.180
 Why?
Sequence Deletion
1
2020
67
0.180
 Why?
Protein Kinase Inhibitors
1
2021
206
0.170
 Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.170
 Why?
Retrospective Studies
6
2022
6134
0.170
 Why?
Glutathione Transferase
1
2020
174
0.170
 Why?
Polymorphism, Genetic
1
2020
181
0.170
 Why?
Virology
1
2018
6
0.160
 Why?
HIV
1
2018
24
0.160
 Why?
Anti-Inflammatory Agents
1
2020
160
0.160
 Why?
Aged
6
2022
9405
0.160
 Why?
Molecular Structure
3
2024
296
0.150
 Why?
Immunotherapy, Adoptive
1
2018
157
0.140
 Why?
Blood Pressure
1
2019
524
0.140
 Why?
Polymorphism, Single Nucleotide
1
2019
485
0.140
 Why?
Odds Ratio
1
2018
546
0.140
 Why?
T-Lymphocytes
1
2018
339
0.130
 Why?
Cross-Sectional Studies
2
2018
1554
0.130
 Why?
Polymerase Chain Reaction
2
2014
454
0.130
 Why?
Cisplatin
3
2022
278
0.130
 Why?
HIV-2
1
2014
1
0.120
 Why?
Hospitals, Military
1
2014
7
0.120
 Why?
Time Factors
2
2018
2922
0.120
 Why?
Drug Monitoring
1
2014
78
0.120
 Why?
Syphilis Serodiagnosis
1
2014
4
0.120
 Why?
Antibodies, Monoclonal
1
2018
460
0.120
 Why?
RNA, Viral
2
2014
126
0.120
 Why?
Peritonitis
1
2014
27
0.120
 Why?
Community-Acquired Infections
1
2014
39
0.120
 Why?
Immunocompromised Host
1
2014
119
0.120
 Why?
Genotype
3
2023
534
0.120
 Why?
Viremia
1
2014
22
0.110
 Why?
Genetic Predisposition to Disease
3
2023
509
0.110
 Why?
Neoplasms
1
2023
1249
0.110
 Why?
Meningitis, Bacterial
1
2013
6
0.110
 Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.110
 Why?
Rubella
1
2012
4
0.110
 Why?
Antiretroviral Therapy, Highly Active
1
2012
34
0.110
 Why?
Toxoplasmosis
1
2012
15
0.110
 Why?
Antibodies, Protozoan
1
2012
12
0.110
 Why?
Gene Frequency
2
2023
94
0.110
 Why?
Bacteria
1
2014
222
0.100
 Why?
Case-Control Studies
3
2020
1126
0.100
 Why?
Bile Ducts, Intrahepatic
2
2022
15
0.100
 Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
 Why?
Pilot Projects
2
2013
697
0.100
 Why?
Drug Screening Assays, Antitumor
2
2024
140
0.100
 Why?
Apoptosis
3
2024
1112
0.100
 Why?
TOR Serine-Threonine Kinases
2
2023
77
0.100
 Why?
Pregnancy Complications, Infectious
1
2012
73
0.100
 Why?
Structure-Activity Relationship
2
2024
401
0.090
 Why?
Deoxycytidine
2
2021
28
0.090
 Why?
Hospitals, Teaching
1
2011
53
0.090
 Why?
Autophagy
2
2023
169
0.090
 Why?
Tumor Microenvironment
2
2024
233
0.090
 Why?
Xenograft Model Antitumor Assays
2
2021
212
0.090
 Why?
Programmed Cell Death 1 Receptor
2
2021
39
0.090
 Why?
Tumor Cells, Cultured
2
2020
468
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
595
0.090
 Why?
Prospective Studies
2
2012
2379
0.080
 Why?
Anti-Bacterial Agents
1
2014
747
0.080
 Why?
Ionic Liquids
1
2024
1
0.060
 Why?
Ablation Techniques
1
2024
21
0.060
 Why?
Hydrogels
1
2024
16
0.060
 Why?
Delayed-Action Preparations
1
2024
51
0.060
 Why?
rho-Associated Kinases
1
2024
20
0.060
 Why?
Hedgehog Proteins
1
2024
33
0.060
 Why?
Blood Banks
2
2014
18
0.060
 Why?
Azoles
1
2023
28
0.060
 Why?
Immunomodulation
1
2024
37
0.060
 Why?
Rabbits
1
2024
374
0.060
 Why?
HLA-DRB1 Chains
1
2023
4
0.060
 Why?
Research
1
2023
109
0.050
 Why?
HLA Antigens
1
2023
53
0.050
 Why?
Interleukin-17
1
2023
36
0.050
 Why?
Pyrazoles
1
2023
114
0.050
 Why?
Medical Oncology
1
2023
95
0.050
 Why?
Computer Simulation
1
2023
280
0.050
 Why?
Platinum
1
2022
11
0.050
 Why?
Sirolimus
1
2023
62
0.050
 Why?
Alleles
1
2023
251
0.050
 Why?
Clone Cells
1
2022
78
0.050
 Why?
Proto-Oncogene Proteins c-akt
1
2023
157
0.050
 Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2023
140
0.050
 Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
 Why?
Program Evaluation
1
2023
354
0.050
 Why?
Pregnancy
3
2014
2604
0.050
 Why?
Enzyme Inhibitors
1
2023
386
0.050
 Why?
Cyclin-Dependent Kinase 2
1
2020
16
0.050
 Why?
Proto-Oncogene Proteins c-kit
1
2020
36
0.050
 Why?
Liver Cirrhosis
1
2023
219
0.050
 Why?
Cytidine Monophosphate
1
2020
1
0.050
 Why?
Curriculum
1
2023
400
0.050
 Why?
Flame Ionization
1
2020
3
0.050
 Why?
Medicine, Traditional
1
2020
18
0.040
 Why?
Mice, Inbred NOD
1
2020
96
0.040
 Why?
Plant Leaves
1
2020
40
0.040
 Why?
Gas Chromatography-Mass Spectrometry
1
2020
67
0.040
 Why?
Mice, SCID
1
2020
176
0.040
 Why?
Aldehydes
1
2020
83
0.040
 Why?
Cytokines
1
2023
613
0.040
 Why?
Genomics
1
2021
285
0.040
 Why?
Lipids
1
2020
148
0.040
 Why?
DNA, Viral
1
2019
134
0.040
 Why?
Sesquiterpenes
1
2020
89
0.040
 Why?
Cell Survival
1
2020
602
0.040
 Why?
Cohort Studies
1
2023
1422
0.040
 Why?
Immunohistochemistry
1
2021
978
0.040
 Why?
Inflammation
1
2023
604
0.040
 Why?
Genetic Association Studies
1
2019
116
0.040
 Why?
CTLA-4 Antigen
1
2018
25
0.040
 Why?
Alcohol Drinking
1
2020
226
0.040
 Why?
Rats
1
2024
3299
0.040
 Why?
Neoplasm Recurrence, Local
1
2021
613
0.040
 Why?
Dose-Response Relationship, Drug
1
2020
1378
0.040
 Why?
Signal Transduction
1
2024
1622
0.040
 Why?
Body Mass Index
1
2020
656
0.040
 Why?
Phenotype
1
2019
733
0.030
 Why?
Smoking
1
2020
512
0.030
 Why?
CD4 Lymphocyte Count
1
2014
32
0.030
 Why?
Aged, 80 and over
1
2022
3154
0.030
 Why?
Opportunistic Infections
1
2014
59
0.030
 Why?
Risk Assessment
1
2019
1262
0.030
 Why?
Reagent Kits, Diagnostic
1
2014
18
0.030
 Why?
Genotyping Techniques
1
2014
20
0.030
 Why?
Hepatitis C Antibodies
1
2014
20
0.030
 Why?
Donor Selection
1
2014
12
0.030
 Why?
Drug Resistance, Bacterial
1
2014
71
0.030
 Why?
Drug Therapy, Combination
1
2014
381
0.030
 Why?
Weight Gain
1
2014
239
0.030
 Why?
Microbial Sensitivity Tests
1
2014
270
0.030
 Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
 Why?
Antibodies, Anti-Idiotypic
1
2012
19
0.030
 Why?
Molecular Diagnostic Techniques
1
2013
32
0.030
 Why?
Water
1
2012
75
0.030
 Why?
Disease Progression
1
2014
831
0.020
 Why?
Comorbidity
1
2014
613
0.020
 Why?
Socioeconomic Factors
1
2012
579
0.020
 Why?
Follow-Up Studies
1
2014
2190
0.020
 Why?
Treatment Outcome
1
2014
5155
0.010
 Why?
Child
1
2012
6851
0.010
 Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (211) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department